The GABAergic system in eye growth control and myopia

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/553003

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Shortsightedness (myopia) is the most common visual disorder. High myopia is associated with an increased risk of eye diseases. Current treatments do not stop myopia developing or decrease the associated risk of eye disease. The continued worsening of myopia is very concerning. A safe effective treatment that can either prevent myopia or stop its progression to extreme levels is needed. We have data showing that GABA ergic drugs modify myopia. This proposal will determine the mechanisms.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $318,142.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Opthalmology And Vision Science

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Eye growth | GABAergic system | Myopia | Optometry | Retina and visual function | Retinal neurotransmitters | Visual function

Related Links